Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takemasa Tsuji

Showing results (11-20 of 60) with videos related to

Pageof 6
Sort By:
Cancer Science|October 9, 2004
The critical role of type-1 innate and acquired immunity in tumor immunotherapyHiroaki Ikeda, Kenji Chamoto, Takemasa Tsuji, et al.
The Journal of Physical Chemistry. A|December 2, 2014
Molecular structure and internal rotation of CF₃ group of methyl trifluoroacetate: gas electron diffraction, microwave spectroscopy, and quantum chemical calculation studiesNobuhiko Kuze, Atsushi Ishikawa, Maho Kono, et al.
Cancer Immunology Research|April 26, 2014
Nonclassical antigen-processing pathways are required for MHC class II-restricted direct tumor recognition by NY-ESO-1-specific CD4(+) T cellsJunko Matsuzaki, Takemasa Tsuji, Immanuel Luescher, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 4, 2006
Influence of CD4+CD25+ regulatory T cells on low/high-avidity CD4+ T cells following peptide vaccinationHiroyoshi Nishikawa, Feng Qian, Takemasa Tsuji, et al.
Cancer Immunology Research|March 29, 2018
Rapid Construction of Antitumor T-cell Receptor Vectors from Frozen Tumors for Engineered T-cell TherapyTakemasa Tsuji, Akira Yoneda, Junko Matsuzaki, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 5, 2008
Inducing efficient cross-priming using antigen-coated yeast particlesShanshan W Howland, Takemasa Tsuji, Sacha Gnjatic, et al.
Immunology Letters|August 25, 2004
NKT cells act as regulatory cells rather than killer cells during activation of NK cell-mediated cytotoxicity by alpha-galactosylceramide in vivoKenji Chamoto, Tsuguhide Takeshima, Akemi Kosaka, et al.
Cancer Science|January 31, 2006
1alpha,25-Dihydroxyvitamin D3 downmodulates the functional differentiation of Th1 cytokine-conditioned bone marrow-derived dendritic cells beneficial for cytotoxic T lymphocyte generationJunko Matsuzaki, Takemasa Tsuji, Yue Zhang, et al.
Gynecologic Oncology|April 23, 2016
HLA superfamily assignment is a predictor of immune response to cancer testis antigens and survival in ovarian cancerJ Brian Szender, Kevin H Eng, Junko Matsuzaki, et al.
Plos One|August 23, 2011
Split T cell tolerance against a self/tumor antigen: spontaneous CD4+ but not CD8+ T cell responses against p53 in cancer patients and healthy donorsTakemasa Tsuji, Junko Matsuzaki, Erika Ritter, et al.
Pageof 6

Showing results (11-20 of 60) with videos related to

Sort By:
Pageof 6
Cancer Science|October 9, 2004
The critical role of type-1 innate and acquired immunity in tumor immunotherapyHiroaki Ikeda, Kenji Chamoto, Takemasa Tsuji, et al.
The Journal of Physical Chemistry. A|December 2, 2014
Molecular structure and internal rotation of CF₃ group of methyl trifluoroacetate: gas electron diffraction, microwave spectroscopy, and quantum chemical calculation studiesNobuhiko Kuze, Atsushi Ishikawa, Maho Kono, et al.
Cancer Immunology Research|April 26, 2014
Nonclassical antigen-processing pathways are required for MHC class II-restricted direct tumor recognition by NY-ESO-1-specific CD4(+) T cellsJunko Matsuzaki, Takemasa Tsuji, Immanuel Luescher, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 4, 2006
Influence of CD4+CD25+ regulatory T cells on low/high-avidity CD4+ T cells following peptide vaccinationHiroyoshi Nishikawa, Feng Qian, Takemasa Tsuji, et al.
Cancer Immunology Research|March 29, 2018
Rapid Construction of Antitumor T-cell Receptor Vectors from Frozen Tumors for Engineered T-cell TherapyTakemasa Tsuji, Akira Yoneda, Junko Matsuzaki, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 5, 2008
Inducing efficient cross-priming using antigen-coated yeast particlesShanshan W Howland, Takemasa Tsuji, Sacha Gnjatic, et al.
Immunology Letters|August 25, 2004
NKT cells act as regulatory cells rather than killer cells during activation of NK cell-mediated cytotoxicity by alpha-galactosylceramide in vivoKenji Chamoto, Tsuguhide Takeshima, Akemi Kosaka, et al.
Cancer Science|January 31, 2006
1alpha,25-Dihydroxyvitamin D3 downmodulates the functional differentiation of Th1 cytokine-conditioned bone marrow-derived dendritic cells beneficial for cytotoxic T lymphocyte generationJunko Matsuzaki, Takemasa Tsuji, Yue Zhang, et al.
Gynecologic Oncology|April 23, 2016
HLA superfamily assignment is a predictor of immune response to cancer testis antigens and survival in ovarian cancerJ Brian Szender, Kevin H Eng, Junko Matsuzaki, et al.
Plos One|August 23, 2011
Split T cell tolerance against a self/tumor antigen: spontaneous CD4+ but not CD8+ T cell responses against p53 in cancer patients and healthy donorsTakemasa Tsuji, Junko Matsuzaki, Erika Ritter, et al.
Pageof 6